The Cellular Interaction of 5-Fluorouracil and Cisplatin in a Human Colon Carcinoma Cell Line

By Johnston P.G.   Geoffrey F.   Drake J.   Voeller D.   Grem J.L.   Allegra C.J.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2148-2154

Elsevier

Access to resources Recommend Favorite

Differential growth inhibition by 5-fluorouracil in human colorectal carcinoma cell lines

By Tokunaga E.   Oda S.   Fukushima M.   Maehara Y.   Sugimachi K.  

European Journal of Cancer, Vol. 36, Iss. 15, 2000-10 ,pp. : 1998-2006

Elsevier

Access to resources Recommend Favorite

Outpatient 5-Fluorouracil, Folinic Acid and Cisplatin in Patients with Advanced Esophageal Carcinoma

By Warner Ellen   Jensen Jorgen L.   Cripps Christine   Khoo Kong E.   Goel Rakesh   Kerr Ian A.   Bjarnason Georg A.   Fields Anthony L. A.   Hrincu Angela  

Acta Oncologica, Vol. 38, Iss. 2, 1999-03 ,pp. : 255-259

Informa Healthcare

Access to resources Recommend Favorite

Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study

By Tanaka Yoshihiro   Yoshida Kazuhiro   Sanada Yuichi   Osada Shinji   Yamaguchi Kazuya   Takahashi Takao  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1159-1165

Springer Publishing Company

Access to resources Recommend Favorite

Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines

By Kitada Noriaki   Takara Kohji   Minegaki Tetsuya   Itoh Chihiro   Tsujimoto Masayuki   Sakaeda Toshiyuki   Yokoyama Teruyoshi  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 4, 2008-09 ,pp. : 577-584

Springer Publishing Company

Access to resources Recommend Favorite